Skip to main content
M

Mabpharm Limited — Investor Relations & Filings

Ticker · 2181 HKEX Manufacturing
Open in API
Filings indexed 221 across all filing types
Latest filing 2025-12-03 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2181

About Mabpharm Limited

http://www.mabpharm.cn

Mabpharm Limited is a biopharmaceutical company focused on the research, development, production, and commercialization of monoclonal antibody (mAb) drugs and biosimilars. The core therapeutic areas include oncology (cancer) and autoimmune diseases. The company emphasizes bringing high-quality, affordable, and innovative biological drugs to the market by utilizing efficient R&D systems and low-cost manufacturing capabilities. Its robust pipeline features multiple candidates, including 9 monoclonal antibody drugs and 1 strong antibody drug.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, share options, and treasury shares. Since it details changes in share capital and securities, it falls under the category of share issues and capital changes.
2025-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a statutory monthly return (Form FF301) filed to the Hong Kong Exchanges and Clearing Limited under Listing Rules Chapter 19B, summarizing movements in authorized/share capital, issued shares, share options, etc. It is not an annual or quarterly financial report, dividend notice, management change, or proxy solicitation, nor a simple announcement of report publication. Instead, it is a routine regulatory filing, making “Regulatory Filings” (RNS) the most appropriate category.
2025-11-05 English
Terms of Reference of the Nomination Committee
Governance Information Classification · 1% confidence The document is the Terms of Reference for the Nomination Committee, detailing its constitution, membership, duties, meeting procedures, and reporting – all elements of internal governance structure. It is not an announcement of a specific event, financial results, or regulatory filing; rather, it defines board committee rules. This falls squarely under Governance Information.
2025-10-31 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 1% confidence The document is a standalone listing of the company’s board members and committee structure, with no mention of changes or events. It outlines the board composition and governance committees, matching “Governance Information” (CGR). It is not announcing a board change (MANG) nor an AGM material, but rather a governance structure disclosure.
2025-10-31 English
(1) DESIGNATION OF LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR AND (2) CHANGES IN COMPOSITION OF THE NOMINATION COMMITTEE
Board/Management Information Classification · 1% confidence The document is an official announcement regarding changes in the board’s composition and the designation of a new lead independent non-executive director, specifically detailing appointments and committee changes. This fits the definition of a Board/Management Information filing.
2025-10-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings Classification · 1% confidence The document is a form FF301 "Monthly Return for Equity Issuer and Hong Kong Depositary Receipts" filed to Hong Kong Exchanges and Clearing Limited under the Listing Rules. It provides monthly regulatory information on authorised capital, issued shares, share options, etc. This is not a financial report itself (10-K, IR) nor an earnings or dividend announcement, but a standard periodic regulatory filing. It does not fall under any more specific category in our taxonomy, so it is classified as a general Regulatory Filing (RNS).
2025-10-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.